171 related items for PubMed ID: 37942512
1. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
Gong X, Huang J, Zhang Y, Wang F, Wang X, Meng L, Cheng X, Liu G, Cui Z, Zhao M.
Ren Fail; 2023; 45(2):2279642. PubMed ID: 37942512
[Abstract] [Full Text] [Related]
2. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
[Abstract] [Full Text] [Related]
3. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV.
Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
[Abstract] [Full Text] [Related]
4. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
[Abstract] [Full Text] [Related]
5. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
[Abstract] [Full Text] [Related]
6. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
Ahmed HM, Ezzat DA, Doudar NA, Adel M.
Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
[Abstract] [Full Text] [Related]
7. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ.
Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
[Abstract] [Full Text] [Related]
8. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[Abstract] [Full Text] [Related]
9. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.
Sci Rep; 2018 Nov 23; 8(1):17322. PubMed ID: 30470792
[Abstract] [Full Text] [Related]
10. Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.
Cara-Fuentes G, Lanaspa MA, Garcia GE, Banks M, Garin EH, Johnson RJ.
Pediatr Nephrol; 2018 Jul 23; 33(7):1101-1103. PubMed ID: 29492674
[Abstract] [Full Text] [Related]
11. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
Eroglu FK, Orhan D, İnözü M, Duzova A, Gulhan B, Ozaltin F, Topaloglu R.
Pediatr Int; 2019 Dec 23; 61(12):1250-1256. PubMed ID: 31513327
[Abstract] [Full Text] [Related]
12. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
Moura LR, Franco MF, Kirsztajn GM.
J Bras Nefrol; 2015 Dec 23; 37(4):475-80. PubMed ID: 26648497
[Abstract] [Full Text] [Related]
13. Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
Pediatr Nephrol; 2015 Feb 23; 30(2):309-16. PubMed ID: 25142334
[Abstract] [Full Text] [Related]
14. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.
Pediatr Nephrol; 2018 Oct 23; 33(10):1773-1780. PubMed ID: 29982878
[Abstract] [Full Text] [Related]
15. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
Clin Exp Nephrol; 2015 Jun 23; 19(3):496-505. PubMed ID: 25230687
[Abstract] [Full Text] [Related]
16. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H, Parvex P, Poncet A, Werner D, Mosig D, Cachat F, Girardin E.
Pediatr Nephrol; 2013 Dec 23; 28(12):2299-306. PubMed ID: 23949592
[Abstract] [Full Text] [Related]
17. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW, Song HC, Shin YS, Ahn SJ, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK.
Nephron; 1998 Dec 23; 79(1):44-9. PubMed ID: 9609461
[Abstract] [Full Text] [Related]
18. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
Kidney Int; 2004 May 23; 65(5):1690-702. PubMed ID: 15086908
[Abstract] [Full Text] [Related]
19. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.
Lan L, Lin Y, Yu B, Wang Y, Pan H, Wang H, Lou X, Lang X, Zhang Q, Jin L, Yang Y, Xiao L, Chen J, Han F.
Am J Nephrol; 2024 May 23; 55(1):25-36. PubMed ID: 37963441
[Abstract] [Full Text] [Related]
20. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
Expert Opin Investig Drugs; 2018 Nov 23; 27(11):839-879. PubMed ID: 30360670
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
